Evidence map›Paper›PMID 7611299›Full record

ArticleAmerican journal of human genetics1995

Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons.

G Nijbroek, S Sood, I McIntosh, C A Francomano, E Bull, L Pereira, F Ramirez, R E Pyeritz, H C Dietz

Open access · greenAbstract read
In one paragraph

Article in American journal of human genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 236 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A novel missense variant ofFrontiers in pediatrics · 2025
    Article
  6. Case Report:Frontiers in genetics · 2025
    Article
  7. Article
  8. Article
  9. The British journal of ophthalmology · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. FBN1 contributing to familial congenital diaphragmatic hernia.American journal of medical genetics. Part A · 2015
    Article
  19. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Article
  20. Observational

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

G NijbroekDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
S Sood
I McIntosh
C A Francomano
E Bull
L Pereira
F Ramirez
R E Pyeritz
H C Dietz
Johns Hopkins Medicine · US

Funding

MOLECULAR BIOLOGY OF THE MARFAN SYNDROMER01AR041135 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI DIETZ, HARRY C., III · 1992 to 2016
$5.2M
DEVELOPMENT OF A TRANSGENIC MODEL OF THE MARFAN SYNDROMEK08HL002815 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DIETZ, HARRY C. · 1992 to 1995
–
CONGENITAL HEART DISEASE: MODELING AND GENETIC ANALYSISR01HL035877 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PYERITZ, REED E · 1986 to 1995
–
NHLBI NIH HHS HL-02815NHLBI NIH HHS HL-35877NIAMS NIH HHS AR-41135
6 · The paper itself

Abstract

Mutations in the gene encoding fibrillin-1 (FBN1), a component of the extracellular microfibril, cause the Marfan syndrome (MFS). This statement is supported by the observations that the classic Marfan phenotype cosegregates with intragenic and/or flanking marker alleles in all families tested and that a significant number of FBN1 mutations have been identified in affected individuals. We have now devised a method to screen the entire coding sequence and flanking splice junctions of FBN1. On completion for a panel of nine probands with classic MFS, six new mutations were identified that accounted for disease in seven (78%) of nine patients. Nine additional new mutations have been characterized in the early stages of a larger screening project. These 15 mutations were equally distributed throughout the gene and, with one exception, were specific to single families. One-third of mutations created premature termination codons, and 6 of 15 substituted residues with putative significance for calcium binding to epidermal growth factor (EGF)-like domains. Mutations causing severe and rapidly progressive disease that presents in the neonatal period can occur in a larger region of the gene than previously demonstrated, and the nature of the mutation is as important a determinant as its location, in predisposing to this phenotype.

Indexed as

DNA Mutational AnalysisBase SequenceChromosome MappingDNAExonsHumansMarfan SyndromeMolecular Sequence DataNucleic Acid HeteroduplexesPolymerase Chain ReactionDNANucleic Acid Heteroduplexes

Identifiers

PMID7611299
PMCPMC1801235
OpenAlexW1555580499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.